If we have any methods to widen CI in parallel design with high variance drug? [RSABE / ABEL]

posted by libaiyi – China, 2021-02-02 09:39 (354 d 12:25 ago) – Posting: # 22199
Views: 1,094

Dear all,

Recently I meet a problem about sample size of high variance drug, normally, we will design a repeated cross-over trial for this kind of drug. But this time it is designed as a parallel study due to some reasons. But the sample size is too much based on 80%-125% BE CI. So my quesion is if we have any method to widen the CI like RSABE in cross-over study? Thank you very mcuh.:-D

Sincerely,
libaiyi

Complete thread:

Activity
 Admin contact
21,835 posts in 4,569 threads, 1,554 registered users;
online 5 (0 registered, 5 guests [including 2 identified bots]).
Forum time: Saturday 22:05 CET (Europe/Vienna)

Science may set limits to knowledge,
but should not set limits to imagination.    Bertrand Russell

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5